Expertise in
2
conditions

Dr. Edward Smith

Pediatric Neurology
Rare Disease Research NC LLC
405 Meadowlands Dr, 
Hillsborough, NC 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Rare Disease Research NC LLC
405 Meadowlands Dr, 
Hillsborough, NC 

Overview

Edward Smith is a Pediatric Neurologist practicing medicine in Hillsborough, North Carolina.

Dr. Smith is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pompe Disease, Muscle Atrophy, Hereditary Ataxia, and Delayed Growth.

He is actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 10 clinical trials.

Specialties

Pediatric Neurology

Licenses

Pediatrics in NC

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Piedmont
  • HMO
  • POS

Locations

Rare Disease Research NC LLC
405 Meadowlands Dr, Hillsborough, NC 27278
Other Locations
Private Diagnostic Clinic PLLC
2100 Erwin Rd, Durham, NC 27705

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Drug, Other
A Phase 1 Study of the Safety of AAV2/8-LSPhGAA (ACTUS-101) in Late-onset Pompe Disease
A Phase 1 Study of the Safety of AAV2/8-LSPhGAA (ACTUS-101) in Late-onset Pompe Disease
Enrollment Status: Completed
Publish Date: April 13, 2026
Intervention Type: Genetic
Study Drug: AAV2/8LSPhGAA
Study Phase: Phase 1
An Open-Label, Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy Who Have Completed the Long-Term Extension (VBP15-LTE) or VBP15-004 or VBP15-006 Studies
An Open-Label, Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy Who Have Completed the Long-Term Extension (VBP15-LTE) or VBP15-004 or VBP15-006 Studies
Enrollment Status: Available
Publish Date: January 20, 2026
Intervention Type: Drug
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)
Enrollment Status: Completed
Publish Date: July 08, 2025
Intervention Type: Genetic
Study Phase: Phase 3
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
Enrollment Status: Completed
Publish Date: November 19, 2024
Intervention Type: Drug
Study Drug: PEG-Zilarginase
Study Phase: Phase 3
A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study With Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys With Duchenne Muscular Dystrophy (DMD)
A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study With Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Completed
Publish Date: March 09, 2023
Intervention Type: Drug, Other
Study Drugs: Vamorolone, Prednisone
Study Phase: Phase 2
A Phase II, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
A Phase II, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Completed
Publish Date: December 07, 2021
Intervention Type: Drug
Study Phase: Phase 2
A 24-month Phase II Open-label, Multicenter Long-term Extension Study to Assess the Long-Term Safety and Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
A 24-month Phase II Open-label, Multicenter Long-term Extension Study to Assess the Long-Term Safety and Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Completed
Publish Date: May 20, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Open-label, Multicenter Extension Study to Assess the Long-term Safety and Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
A Phase II Open-label, Multicenter Extension Study to Assess the Long-term Safety and Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Completed
Publish Date: July 23, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase IIa Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
A Phase IIa Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Completed
Publish Date: January 02, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

48 Total Publications

Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children.
Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children.
Journal: Steroids
Published: August 11, 2025
Similar Doctors
Expertise in
3
conditions
Dr. Darrell Lewis
Pediatric Neurology
Expertise in
3
conditions
Dr. Darrell Lewis
Pediatric Neurology
Referral may be required

Office

2100 Erwin Rd, 
Durham, NC 
 (0.1 miles away)
919-620-4467
Languages Spoken:
English

Darrell Lewis is a Pediatric Neurologist practicing medicine in Durham, North Carolina. Dr. Lewis is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Status Epilepticus, Seizures, and Partial Familial Epilepsy.

Expertise in
5
conditions
Dr. Yael Shiloh
Pediatric Neurology
Expertise in
5
conditions
Dr. Yael Shiloh
Pediatric Neurology
Referral may be required

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (9.8 miles away)
919-966-2528
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Yael Shiloh is a Pediatric Neurologist practicing medicine in Chapel Hill, North Carolina. Dr. Shiloh is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Myoclonic Epilepsy, Seizures, Generalized Tonic-Clonic Seizure, and Epilepsy with Myoclonic-Atonic Seizures.

Expertise in
1
conditions
Dr. Senyene Hunter
Pediatric Neurology
Expertise in
1
conditions
Dr. Senyene Hunter
Pediatric Neurology
Referral may be required

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (9.8 miles away)
919-966-4131
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Senyene Hunter is a Pediatric Neurologist practicing medicine in Chapel Hill, North Carolina. Dr. Hunter is highly rated in 1 condition, according to our data. Her clinical expertise encompasses West Syndrome, Epilepsy in Children, Spasmus Nutans, and Primary Lateral Sclerosis.

Frequently Asked Questions about Dr. Edward Smith

How do I make an appointment with Dr. Edward Smith?

You can book an appointment with Dr. Edward Smith by calling their office at 984-314-2252. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Edward Smith a top-rated expert for Pompe Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Edward Smith is classified as an Advanced expert for Pompe Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Edward Smith specialize in?

While Dr. Edward Smith is a Pediatric Neurology, they have specific expertise in Pompe Disease, Muscle Atrophy, and Hereditary Ataxia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Neurology.

Does Dr. Edward Smith participate in research or clinical trials?

Yes. Dr. Edward Smith has published 48 articles and abstracts on conditions like Pompe Disease. You can view a list of Dr. Edward Smith's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Edward Smith accept my insurance?

Dr. Edward Smith accepts most major insurance plans, including Humana and Piedmont. We recommend calling the office directly at 984-314-2252 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Smith's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile